Logo image of DNLI

DENALI THERAPEUTICS INC (DNLI) Stock Analyst Ratings

NASDAQ:DNLI - Nasdaq - US24823R1059 - Common Stock - Currency: USD

20.73  -0.86 (-3.98%)

After market: 20.95 +0.22 (+1.06%)

Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to DNLI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 41.02. This target is 97.87% above the current price.
DNLI was analyzed by 24 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about DNLI.
In the previous month the buy percentage consensus was at a similar level.
DNLI was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
DNLI Historical Analyst RatingsDNLI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -84 -76 -68 -60 -52 -44 -36 -28 -20 -12 -4 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 20.7329.2938.2541.0291.35 - 41.29% 84.52% 97.87% 340.67%
DNLI Current Analyst RatingDNLI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-02-11 Deutsche Bank Initiate Buy
2025-01-28 Goldman Sachs Maintains Buy -> Buy
2025-01-07 JP Morgan Maintains Overweight -> Overweight
2025-01-07 Baird Initiate Outperform
2025-01-07 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-03 William Blair Initiate Outperform
2024-12-16 Stifel Upgrade Hold -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-01 Jefferies Maintains Buy -> Buy
2024-10-11 JP Morgan Maintains Overweight -> Overweight
2024-10-10 Raymond James Reiterate Market Perform
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-04 B of A Securities Maintains Buy -> Buy
2024-09-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Wedbush Maintains Outperform -> Outperform
2024-08-02 Citigroup Maintains Buy -> Buy
2024-07-10 JP Morgan Maintains Overweight -> Overweight
2024-05-08 Stifel Maintains Hold -> Hold
2024-05-08 Wedbush Maintains Outperform -> Outperform
2024-05-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-09 UBS Maintains Buy -> Buy
2024-02-29 Goldman Sachs Maintains Buy -> Buy
2024-02-28 Wedbush Reiterate Outperform -> Outperform
2024-02-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-13 Citigroup Initiate Buy
2023-11-20 JP Morgan Reiterate Overweight
2023-11-08 Wedbush Reiterate Outperform -> Outperform